Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Dec 15, 2025, 7:30 AM EST - 12 days ago
Dec 11, 2025, 8:30 AM EST - 16 days ago
Nov 24, 2025, 8:15 AM EST - 4 weeks ago
Nov 19, 2025, 5:44 PM EST - 5 weeks ago
Oct 30, 2025, 7:30 AM EDT - 2 months ago
Oct 28, 2025, 8:30 AM EDT - 2 months ago
Oct 22, 2025, 8:30 AM EDT - 2 months ago
Oct 7, 2025, 8:15 AM EDT - 2 months ago
Oct 1, 2025, 8:30 AM EDT - 3 months ago
Sep 11, 2025, 8:30 AM EDT - 3 months ago
Sep 4, 2025, 8:30 AM EDT - 4 months ago
Aug 27, 2025, 8:45 AM EDT - 4 months ago
Aug 19, 2025, 8:15 AM EDT - 4 months ago
Aug 6, 2025, 8:15 AM EDT - 5 months ago
Jul 31, 2025, 8:15 AM EDT - 5 months ago
Jul 21, 2025, 8:00 AM EDT - 5 months ago
Jul 11, 2025, 4:00 PM EDT - 6 months ago